zadnja posodobitev :
19/11/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Amsacrine
Kemična formula
Lastniško ime
Sestava pomožnih snovi je med paralelami lahko različna
Amekrin
Danska, Finska, Norveška, Švedska
Amsa PD
Kanada
Amsalyo
Francija
Amsidine
Avstralija, Belgija, Italija, Nizozemska
Amsidyl
Nemčija, Švica
Viri : Amsacrine
Tip
objava
182
časopis
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
253
časopis
Trissel LA, Chandler SW, Folstad JT.
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2525-2528.
334
časopis
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
časopis
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
492
časopis
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
829
časopis
Cartwright-Shamoon JM, McElnay JC, D'Arcy PF.
Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets.
Int J Pharm 1988 ; 42: 41-46.
3523
Traduction Laboratorij
Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018
3576
Traduction Laboratorij
Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit
Prostrakan 2012
3595
Traduction Laboratorij
Aciclovir - Summary of Product Characteristics
Hospira 2009
3745
časopis
Kuenhle C, Moore
Sodium chloride residue provides potential for drug incompatibiities.
Am J Hosp Pharm 1979 ; 36: 881.
Mentions Légales